🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Thymosin Beta 4 (Tβ4) is a synthetic copy of the naturally-occurring 43-ami...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01387347
Treatments Being Tested
As a consequence of damage to multiple organ systems throughout the course ...
Status
Terminated
Location
United Medical Research Institute
Start Date
2007-12
Trial ID
NCT00598871
Treatments Being Tested
Severe dry eye is a debilitating ocular disease resulting in loss of vision...
Status
Completed
Location
Michigan Cornea Consultants, P.C.
Start Date
2011-03
Trial ID
NCT01393132
Treatments Being Tested
The objective of this study is to compare the safety and efficacy of RGN-25...
Status
Completed
Location
Andover, MA
Start Date
2015-09
Trial ID
NCT02597803
The objective of this study is to compare the safety and efficacy of RGN-25...
Status
Completed
Location
Andover, MA
Start Date
2016-11
Trial ID
NCT02974907
The purpose of this study is to evaluate the safety, tolerability and effec...
Status
Completed
Location
Chirurgia Vascolare
Start Date
2006-07
Trial ID
NCT00832091
Treatments Being Tested
The objective of this study is to compare the safety and efficacy of RGN-25...
Status
Completed
Location
Cornea and Cataract Consultants of Arizona
Start Date
2019-05-24
Trial ID
NCT03937882
The objective of this study is to evaluate the safety and tolerability of t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-07
Trial ID
NCT01311518
Treatments Being Tested
The objective of this study is to compare the safety and efficacy of RGN-25...
Status
Recruiting
Location
Harvard Eye Associates
Start Date
2023-04-11
Trial ID
NCT05555589
The objective of this study is to evaluate the safety, tolerance, pharmacok...
Status
Completed
Location
Beijing Shijitan Hospital
Start Date
2018-07-30
Trial ID
NCT04555850
Treatments Being Tested